A Gender Factor in Shaping T-Cell Immunity to Melanoma

por Dronca, Roxana S., Dong, Haidong
Publicado 2015

Cardiac Metastasis in Renal Cell Carcinoma without Vena Cava or Atrial Involvement: an Unusual Presentation of Metastatic Disease

por Zhang, Ben, Malouf, Joseph, Young, Phillip, Kohli, Manish, Dronca, Roxana
Publicado 2013

Paradox-driven adventures in the development of cancer immunology and immunotherapy

por Barham, Whitney, Gicobi, Joanina K., Yan, Yiyi, Dronca, Roxana S., Dong, Haidong
Publicado 2019

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients

por Dronca, Roxana, Liu, Xin, Lisa, Kottschade, Mcwilliams, Rob, Markovic, Svetomir, Dong, Haidong
Publicado 2015

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

por Yan, Yiyi, Kumar, Anagha Bangalore, Finnes, Heidi, Markovic, Svetomir N., Park, Sean, Dronca, Roxana S., Dong, Haidong
Publicado 2018

Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors — a major reason for enhanced chemosensitivity?

por Shenoy, Niraj, Dronca, Roxana, Quevedo, Fernando, Boorjian, Stephen A, Cheville, John, Costello, Brian, Kohli, Manish, Witzig, Thomas, Pagliaro, Lance
Publicado 2017

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy

por Enninga, Elizabeth Ann L., Harrington, Susan M., Creedon, Douglas J., Ruano, Rodrigo, Markovic, Svetomir N., Dong, Haidong, Dronca, Roxana S.
Publicado 2017

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

por Youland, Ryan S., Packard, Ann T., Blanchard, Miran J., Arnett, Andrea L., Wiseman, Gregory A., Kottschade, Lisa A., Dronca, Roxana S., Markovic, Svetomir N., Olivier, Kenneth R., Park, Sean S.
Publicado 2017

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

por Vera Aguilera, Jesus, Paludo, Jonas, McWilliams, Robert R., Zhang, Henan, Li, Ying, Kumar, Anagha B., Failing, Jarrett, Kottschade, Lisa A., Block, Matthew S., Markovic, Svetomir N., Dong, Haidong, Dronca, Roxana S., Yan, Yiyi
Publicado 2020

Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications

por ReFaey, Karim, Tripathi, Shashwat, Grewal, Sanjeet S., Bhargav, Adip G., Quinones, David J., Chaichana, Kaisorn L., Antwi, Samuel O., Cooper, Leslie T., Meyer, Fredric B., Dronca, Roxana S., Diasio, Robert B., Quinones-Hinojosa, Alfredo
Publicado 2021

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011

por Enninga, Elizabeth Ann L., Moser, Justin C., Weaver, Amy L., Markovic, Svetomir N., Brewer, Jerry D., Leontovich, Alexey A., Hieken, Tina J., Shuster, Lynne, Kottschade, Lisa A., Olariu, Ariadna, Mansfield, Aaron S., Dronca, Roxana S.
Publicado 2017

Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021

por Pritchett, Joshua C., Borah, Bijan J., Dholakia, Ruchita, Moriarty, James P., Ahn, Hannah H., Huang, Ming, Khera, Nandita, Wilshusen, Laurie, Dronca, Roxana S., Ticku, Jonathan, Leppin, Aaron L., Tilburt, Jon C., Paludo, Jonas, Haddad, Tufia C.
Publicado 2023

Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma

por Giridhar, Karthik V., Sosa, Carlos P., Hillman, David W., Sanhueza, Cristobal, Dalpiaz, Candace L., Costello, Brian A., Quevedo, Fernando J., Pitot, Henry C., Dronca, Roxana S., Ertz, Donna, Cheville, John C., Donkena, Krishna Vanaja, Kohli, Manish
Publicado 2017

ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance

por Orme, Jacob J., Jazieh, Khalid A., Xie, Tiancheng, Harrington, Susan, Liu, Xin, Ball, Matthew, Madden, Benjamin, Charlesworth, M. Cristine, Azam, Tariq U., Lucien, Fabrice, Wootla, Bharath, Li, Yanli, Villasboas, Jose Caetano, Mansfield, Aaron S., Dronca, Roxana S., Dong, Haidong
Publicado 2020

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles

por Orme, Jacob J, Enninga, Elizabeth Ann L, Lucien-Matteoni, Fabrice, Dale, Heather, Burgstaler, Edwin, Harrington, Susan M, Ball, Matthew K, Mansfield, Aaron S, Park, Sean S, Block, Mathew S, Markovic, Svetomir N, Yan, Yiyi, Dong, Haidong, Dronca, Roxana S, Winters, Jeffrey L
Publicado 2020

Contraction of T cell richness in lung cancer brain metastases

por Mansfield, Aaron S., Ren, Hongzheng, Sutor, Shari, Sarangi, Vivekananda, Nair, Asha, Davila, Jaime, Elsbernd, Laura R., Udell, Julia B., Dronca, Roxana S., Park, Sean, Markovic, Svetomir N., Sun, Zhifu, Halling, Kevin C., Nevala, Wendy K., Aubry, Marie Christine, Dong, Haidong, Jen, Jin
Publicado 2018

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

por Gangadhar, Tara C., Hwu, Wen-Jen, Postow, Michael A., Hamid, Omid, Daud, Adil, Dronca, Roxana, Joseph, Richard, O’Day, Steven J., Hodi, F.S., Pavlick, Anna C., Kluger, Harriet, Oxborough, Romina P., Yang, Aiming, Gazdoiu, Mihaela, Kush, Debra A., Ebbinghaus, Scot, Salama, April K.S.
Publicado 2017

Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program

por Jones, Jeremy C, Golafshar, Michael A, Coston, Tucker W, Rao, Rohit, Wysokinska, Ewa, Johnson, Elizabeth, Esplin, Edward D, Nussbaum, Robert L, Heald, Brandie, Klint, Margaret, Barrus, Kathleen, Uson Jr., Pedro L, Nguyen, Cuong C, Colon-Otero, Gerald, Bekaii-Saab, Tanios S, Dronca, Roxana, Kunze, Katie L, Samadder, N. Jewel
Publicado 2023

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

por DeLeon, Thomas T., Almquist, Daniel R., Kipp, Benjamin R., Langlais, Blake T., Mangold, Aaron, Winters, Jennifer L., Kosiorek, Heidi E., Joseph, Richard W., Dronca, Roxana S., Block, Matthew S., McWilliams, Robert R., Kottschade, Lisa A., Rumilla, Kandelaria M., Voss, Jesse S., Seetharam, Mahesh, Sekulic, Aleksandar, Markovic, Svetomir N., Bryce, Alan H.
Publicado 2020

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

por Hodi, F Stephen, Ribas, Antoni, Daud, Adil, Hamid, Omid, Robert, Caroline, Kefford, Richard, Hwu, Wen-Jen, Gangadhar, Tara C, Joshua, Anthony M, Hersey, Peter, Weber, Jeffrey, Joseph, Richard W, Zarour, Hassane, Dronca, Roxana, Gammage, Linda, Hille, Darcy, Xue, Dahai, Kang, S Peter, Chun, Patrick, Ebbinghaus, Scot W, Perrone, Andrea, Wolchok, Jedd D
Publicado 2014